Mateusz Olbromski

979 total citations
43 papers, 717 citations indexed

About

Mateusz Olbromski is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mateusz Olbromski has authored 43 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Mateusz Olbromski's work include Cancer-related molecular mechanisms research (7 papers), Trace Elements in Health (6 papers) and MicroRNA in disease regulation (5 papers). Mateusz Olbromski is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Trace Elements in Health (6 papers) and MicroRNA in disease regulation (5 papers). Mateusz Olbromski collaborates with scholars based in Poland, Sweden and Czechia. Mateusz Olbromski's co-authors include Piotr Dzięgiel, Marzenna Podhorska‐Okołów, Manuel David Peris‐Díaz, Bartosz Puła, Jan Korbecki, Jędrzej Grzegrzółka, Agnieszka Gomułkiewicz, Aleksandra Piotrowska, Wojciech Witkiewicz and Christopher Kobierzycki and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Mateusz Olbromski

42 papers receiving 711 citations

Peers

Mateusz Olbromski
Aki Isobe Japan
Tania L. Slatter New Zealand
Denis Talbot United Kingdom
Ana Coelho Portugal
Aki Isobe Japan
Mateusz Olbromski
Citations per year, relative to Mateusz Olbromski Mateusz Olbromski (= 1×) peers Aki Isobe

Countries citing papers authored by Mateusz Olbromski

Since Specialization
Citations

This map shows the geographic impact of Mateusz Olbromski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mateusz Olbromski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mateusz Olbromski more than expected).

Fields of papers citing papers by Mateusz Olbromski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mateusz Olbromski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mateusz Olbromski. The network helps show where Mateusz Olbromski may publish in the future.

Co-authorship network of co-authors of Mateusz Olbromski

This figure shows the co-authorship network connecting the top 25 collaborators of Mateusz Olbromski. A scholar is included among the top collaborators of Mateusz Olbromski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mateusz Olbromski. Mateusz Olbromski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olbromski, Mateusz. (2024). Prognostic significance of alpha-2-macrglobulin and low-density lipoprotein receptor-related protein-1 in various cancers. American Journal of Cancer Research. 14(6). 3036–3058. 1 indexed citations
2.
Chachaj, Angelika, I. Stanimirova, Mariusz Chabowski, et al.. (2024). Association between skin lymphangiogenesis parameters and arterial hypertension status in patients: An observational study. Advances in Clinical and Experimental Medicine. 34(1). 63–73.
3.
Olbromski, Mateusz, et al.. (2024). New insights into the role of tetraspanin 6, 7, and 8 in physiology and pathology. Cancer Medicine. 13(14). e7390–e7390. 1 indexed citations
4.
Bromke, Mariusz A., Mateusz Olbromski, Kamila Środa-Pomianek, et al.. (2024). Lipidomics Analysis of Human HMC3 Microglial Cells in an In Vitro Model of Metabolic Syndrome. Biomolecules. 14(10). 1238–1238. 1 indexed citations
5.
Olbromski, Mateusz, et al.. (2024). The VISTA/VSIG3/PSGL-1 axis: crosstalk between immune effector cells and cancer cells in invasive ductal breast carcinoma. Cancer Immunology Immunotherapy. 73(8). 136–136. 7 indexed citations
7.
Rusak, Agnieszka, Benita Wiatrak, Mateusz Olbromski, et al.. (2023). Multimodal study of CHI3L1 inhibition and its effect on angiogenesis, migration, immune response and refractive index of cellular structures in glioblastoma. Biomedicine & Pharmacotherapy. 161. 114520–114520. 11 indexed citations
8.
Grzegrzółka, Jędrzej, Aleksandra Piotrowska, Mateusz Olbromski, et al.. (2023). The Expression of Testin, Ki-67 and p16 in Cervical Cancer Diagnostics. Current Issues in Molecular Biology. 45(1). 490–500. 11 indexed citations
9.
Chachaj, Angelika, I. Stanimirova, Mariusz Chabowski, et al.. (2023). Sodium accumulation in the skin is associated with higher density of skin lymphatic vessels in patients with arterial hypertension. Advances in Medical Sciences. 68(2). 276–289. 6 indexed citations
10.
Dziadkowiak, Edyta, Dagmara Baczyńska, Mateusz Olbromski, et al.. (2023). miR-31-5p as a Potential Circulating Biomarker and Tracer of Clinical Improvement for Chronic Inflammatory Demyelinating Polyneuropathy. Oxidative Medicine and Cellular Longevity. 2023. 1–11. 7 indexed citations
11.
Grzegrzółka, Jędrzej, Agnieszka Gomułkiewicz, Mateusz Olbromski, et al.. (2019). Expression of tesmin (MTL5) in non‑small cell lung cancer: A preliminary study. Oncology Reports. 42(1). 253–262. 6 indexed citations
12.
Glatzel-Plucińska, Natalia, Aleksandra Piotrowska, Jędrzej Grzegrzółka, et al.. (2018). SATB1 Level Correlates with Ki-67 Expression and Is a Positive Prognostic Factor in Non-small Cell Lung Carcinoma. Anticancer Research. 38(2). 723–736. 17 indexed citations
13.
Puła, Bartosz, et al.. (2018). Expression of Metallothionein I/II and Ki-67 Antigen in Graves' Disease. Anticancer Research. 38(12). 6847–6853. 3 indexed citations
14.
Wojtczak, Beata, Bartosz Puła, Agnieszka Gomułkiewicz, et al.. (2017). Metallothionein Isoform Expression in Benign and Malignant Thyroid Lesions. Anticancer Research. 37(9). 5179–5185. 13 indexed citations
15.
Ciesielska, Urszula, Tomasz Zatoński, Katarzyna Nowińska, et al.. (2017). Expression of Cell Cycle-related Proteins p16, p27 and Ki-67 Proliferating Marker in Laryngeal Squamous Cell Carcinomas and in Laryngeal Papillomas. Anticancer Research. 37(5). 2407–2415. 23 indexed citations
16.
Jankowska‐Konsur, Alina, Christopher Kobierzycki, Adam Reich, et al.. (2016). Expression of SOX18 in Mycosis Fungoides. Acta Dermato Venereologica. 97(1). 17–23. 7 indexed citations
17.
Borska, Sylwia, Katarzyna Nowińska, Bartosz Puła, et al.. (2016). Classical and atypical resistance of cancer cells as a target for resveratrol. Oncology Reports. 36(3). 1562–1568. 9 indexed citations
18.
Olbromski, Mateusz, Jędrzej Grzegrzółka, Alina Jankowska‐Konsur, et al.. (2016). MicroRNAs modulate the expression of the SOX18 transcript in lung squamous cell carcinoma. Oncology Reports. 36(5). 2884–2892. 20 indexed citations
19.
Grzegrzółka, Jędrzej, Bartosz Puła, Mateusz Olbromski, et al.. (2013). ACE and ACE2 expression in normal and malignant skin lesions. Folia Histochemica et Cytobiologica. 51(3). 232–238. 17 indexed citations
20.
Puła, Bartosz, Mateusz Olbromski, Andrzej Wojnar, et al.. (2013). Impact of SOX18 expression in cancer cells and vessels on the outcome of invasive ductal breast carcinoma. Cellular Oncology. 36(6). 469–483. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026